Company Profile: Covalent Laboratories Private Limited
Covalent Laboratories Private Limited is a distinguished Active Pharmaceutical Ingredient (API) manufacturer and supplier based in Hyderabad, Telangana, India. Established in 2002, the company operates within the vital Biotech and Life Sciences sector, with a core specialization in the development and large-scale manufacturing of high-value, low-volume drugs, particularly the Cephalosporin class of antibiotics and their intermediates.
Continue…Core Business and Specialization
The primary activity of Covalent Laboratories is the Manufacture of pharmaceuticals, medicinal chemicals, and botanical products. The company functions as a bulk drug manufacturer, supplying Active Pharmaceutical Ingredients (APIs) and intermediates to both the domestic Indian market and international regulated and semi-regulated markets. This focus on APIs is central to the global pharmaceutical supply chain, as their products form the biologically active component of finished drug products.
The company's operational model emphasizes rigorous quality control and assurance, adhering to stringent international standards. It is certified by numerous global regulatory bodies, underscoring its commitment to quality and compliance for its entire product range.
Products and Services
Covalent Laboratories' portfolio is highly focused on a wide range of Cephalosporin APIs and related pharmaceutical intermediates, which are critical in treating various bacterial infections. They manufacture these products in bulk quantities, meeting international pharmacopeia standards such as USP (United States Pharmacopeia), BP (British Pharmacopoeia), and JP (Japanese Pharmacopoeia).
Key Active Pharmaceutical Ingredients (APIs) and Bulk Drugs Offered
The company???s primary product lines include, but are not limited to, the following Cephalosporin compounds:
- Oral Cephalosporins:
- Cefdinir
- Cefixime (including Cefixime Trihydrate)
- Cefprozil
- Cefpodoxime Proxetil
- Cefuroxime (including Cefuroxime Axetil)
- Sterile/Injectable Cephalosporins:
- Cefotaxime Sodium Sterile
- Ceftriaxone Sodium Sterile
- Cefepime Injection
- Intermediates and Other Pharmaceutical Raw Materials:
- The company also manufactures key Cephalosporin intermediates like 7-Amino Cephalosporanic Acid (7-ACA) derivatives (e.g., 7AVCA, 7AVNA).
- Drugs intermediates.
- Croscarmellose Sodium (a common pharmaceutical excipient).
- Pharmaceutical Bulk Drugs.
Manufacturing and Quality Assurance Services
Covalent Laboratories provides its bulk manufacturing services utilizing state-of-the-art production facilities, which are equipped with large-capacity glass-lined reactors (ranging from 630 liters to 3000 liters), centrifuges, Rotocone Driers, and Micronizers. The company maintains professionally managed Quality Assurance (QA) and Quality Control (QC) laboratories to ensure products consistently surpass international quality benchmarks.
A significant aspect of their service is an aggressive Process Development Lab, focused on optimizing manufacturing processes to achieve cost reduction, thereby enabling competitive pricing for their customers globally.
Accreditations and Certifications
The company's adherence to global manufacturing standards is demonstrated by its extensive list of certifications:
- WHO-GMP (World Health Organization ??? Good Manufacturing Practices)
- USFDA (U.S. Food and Drug Administration)
- KFDA (Korean Food and Drug Administration)
- EU-GMP (European Union ??? Good Manufacturing Practices)
- ISO 9001:2008 (Quality Management System)
- ISO 14001:2004 (Environmental Management System)
These accreditations are crucial to their business, facilitating the export of their Active Pharmaceutical Ingredients to highly regulated markets worldwide.
